These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 16628969

  • 1. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC, Kanarek MS.
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A, Nishimura T, Kanno J.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009 Mar; (127):15-25. PubMed ID: 20306702
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
    Thomas T, Bahadori T, Savage N, Thomas K.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Mar; 1(4):426-33. PubMed ID: 20049808
    [Abstract] [Full Text] [Related]

  • 13. The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applications.
    Wood M, Pichard A, Gundert-Remy U, de Rooij C, Tissot SM.
    J Hazard Mater; 2006 May 20; 133(1-3):8-15. PubMed ID: 16343752
    [Abstract] [Full Text] [Related]

  • 14. Conceptual modeling for identification of worst case conditions in environmental risk assessment of nanomaterials using nZVI and C60 as case studies.
    Grieger KD, Hansen SF, Sørensen PB, Baun A.
    Sci Total Environ; 2011 Sep 01; 409(19):4109-24. PubMed ID: 21737121
    [Abstract] [Full Text] [Related]

  • 15. Nanotoxicology and nanotechnology: new findings from the NIEHS and Superfund Research Program scientific community.
    Carlin DJ.
    Rev Environ Health; 2014 Sep 01; 29(1-2):105-7. PubMed ID: 24695034
    [Abstract] [Full Text] [Related]

  • 16. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR, George S, Horst AM, Ji Z, Miller RJ, Peralta-Videa JR, Xia T, Pokhrel S, Mädler L, Gardea-Torresdey JL, Holden PA, Keller AA, Lenihan HS, Nel AE, Zink JI.
    ACS Nano; 2011 Jan 25; 5(1):13-20. PubMed ID: 21261306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH, Pohl HR.
    Regul Toxicol Pharmacol; 2005 Jul 25; 42(2):202-8. PubMed ID: 15921839
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.